• Quote

  • Summary
  • Price Reports
  • Price History
  • Update Stocklist
  • View your Stocklist

• Charts

  • Basic Chart
  • Interactive Chart

• News

  • Headlines

• Financials

  • Company Snapshot
  • Summary Reports
  • Free Annual Report

• Analyst View

  • Estimate Snapshot
  • Estimate Report

• Resources

  • Mobile Quote
  • Real-Time Quote
  • Streaming Quote

close

Par Pharmaceutical Companies | PRX-N

• Update report
• Print

• US$ 24.070
• -1.320
• -5.20%
• 16:03:42 EST Feb 09, 2010

Open			Mkt Cap ($Mil)	837
High			EPS (ttm)
Low			P/E (ttm)
Bid			Forward P/E	13.99
Ask			PEG (est. 5 yrs)	0.20
Volume			Annual Div.
52-wk High 12/31	27.930		Yield
52-wk Low 04/01	8.570		5-star Rating

Quotes delayed 15 minutes.

Intraday Stock Activity Measures

Recent News

Annual Financials

3-Yr. Growth % Dec 2008 12 Mo us$ Dec 2007 12 Mo us$ Dec 2006 12 Mo us$ Total Revenue ($Mil) 10.10 578.11 769.66 725.16 Sales/Share - 17.35 22.31 - Profit ($Mil) - -47.76 51.11 6.74 EPS - -1.43 1.45 0.19 Cash Flow/Share - -1.38 1.48 - Book Value/Share - 11.73 12.94 11.71 Ret on Common Equity - -11.34 11.90 1.59 Debt to Equity - 0.35 0.53 0.49

Earnings Per Share Trend (US$) Sales Per Share Trend (US$)

View Company Snapshot    View Full Financials   

Competitors

Earnings Estimates

Analyst Estimates Currency: US$   Current Qtr Next Qtr Fiscal Yr Fiscal Yr   Dec 2009 Mar 2010 Dec 2009 Dec 2010 Mean Estimated EPS 0.57 0.50 2.48 1.72 Year Ago EPS 0.21 0.49 0.05 2.48 Growth Rate (vs. Year Ago) 171.43% 2.04% 4,860.00% -30.65% Number of Brokers 7 4 7 7 Current High Estimate 0.70 0.58 2.60 2.00 Current Low Estimate 0.46 0.42 2.35 1.51 Current Median EPS 0.56 0.50 2.47 1.67 Consensus Recommendation: Buy (7 brokers)

Estimated EPS vs. Actual EPS

View Full Estimates Snapshots